GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renhe Pharmacy Co Ltd (SZSE:000650) » Definitions » Cyclically Adjusted PB Ratio

Renhe Pharmacy Co (SZSE:000650) Cyclically Adjusted PB Ratio : 1.68 (As of Jun. 04, 2025)


View and export this data going back to 1996. Start your Free Trial

What is Renhe Pharmacy Co Cyclically Adjusted PB Ratio?

As of today (2025-06-04), Renhe Pharmacy Co's current share price is ¥5.60. Renhe Pharmacy Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ¥3.34. Renhe Pharmacy Co's Cyclically Adjusted PB Ratio for today is 1.68.

The historical rank and industry rank for Renhe Pharmacy Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

SZSE:000650' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.59   Med: 3.54   Max: 21.46
Current: 1.69

During the past years, Renhe Pharmacy Co's highest Cyclically Adjusted PB Ratio was 21.46. The lowest was 1.59. And the median was 3.54.

SZSE:000650's Cyclically Adjusted PB Ratio is ranked better than
56.32% of 696 companies
in the Drug Manufacturers industry
Industry Median: 1.975 vs SZSE:000650: 1.69

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Renhe Pharmacy Co's adjusted book value per share data for the three months ended in Mar. 2025 was ¥4.530. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥3.34 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Renhe Pharmacy Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Renhe Pharmacy Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renhe Pharmacy Co Cyclically Adjusted PB Ratio Chart

Renhe Pharmacy Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.83 3.80 2.24 2.21 1.76

Renhe Pharmacy Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.13 1.88 1.98 1.76 1.65

Competitive Comparison of Renhe Pharmacy Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Renhe Pharmacy Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Renhe Pharmacy Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Renhe Pharmacy Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Renhe Pharmacy Co's Cyclically Adjusted PB Ratio falls into.


;
;

Renhe Pharmacy Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Renhe Pharmacy Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=5.60/3.34
=1.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Renhe Pharmacy Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Renhe Pharmacy Co's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=4.53/115.1156*115.1156
=4.530

Current CPI (Mar. 2025) = 115.1156.

Renhe Pharmacy Co Quarterly Data

Book Value per Share CPI Adj_Book
201506 1.751 99.500 2.026
201509 1.832 100.500 2.098
201512 1.929 100.600 2.207
201603 2.013 102.200 2.267
201606 2.072 101.400 2.352
201609 2.148 102.400 2.415
201612 2.222 102.600 2.493
201703 2.286 103.200 2.550
201706 2.253 103.100 2.516
201709 2.331 104.100 2.578
201712 2.430 104.500 2.677
201803 2.515 105.300 2.749
201806 2.527 104.900 2.773
201809 2.647 106.600 2.858
201812 2.739 106.500 2.961
201903 2.854 107.700 3.051
201906 2.899 107.700 3.099
201909 2.993 109.800 3.138
201912 3.073 111.200 3.181
202003 3.156 112.300 3.235
202006 3.169 110.400 3.304
202009 2.894 111.700 2.982
202012 3.638 111.500 3.756
202103 3.731 112.662 3.812
202106 3.658 111.769 3.768
202109 3.576 112.215 3.668
202112 3.777 113.108 3.844
202203 3.888 114.335 3.915
202206 3.903 114.558 3.922
202209 4.015 115.339 4.007
202212 4.101 115.116 4.101
202303 4.231 115.116 4.231
202306 4.155 114.558 4.175
202309 4.287 115.339 4.279
202312 4.281 114.781 4.293
202403 4.379 115.227 4.375
202406 4.495 114.781 4.508
202409 4.356 115.785 4.331
202412 4.410 114.893 4.419
202503 4.530 115.116 4.530

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Renhe Pharmacy Co  (SZSE:000650) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Renhe Pharmacy Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Renhe Pharmacy Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Renhe Pharmacy Co Business Description

Traded in Other Exchanges
N/A
Address
No. 998, Honggutan Road, Greenland Central Plaza, 18th Floor, Yuanchuang International, Zone B, Honggutan New District, Jiangxi Province, Nanchang, CHN, 330038
Renhe Pharmacy Co Ltd is a China-based company engaged in the production and sale of Chinese and Western medicine, bulk drugs and health-related products. The products include oral solid preparations, oral liquid preparations, large-volume injections, small-volume injections, topical lotions, tinctures, suppositories, ointments and other pharmaceutical products and health-related products. The company's main products are Renhe Kelik, Youkadan series, Fu Yan Jie series, Dahuoluo capsules, shiny eye drops, Qinghuo capsules, Zhengwei capsules and others.
Executives
Yang Xiao Director
Kang Zhi Hua Supervisors
Mei Qiang Directors, executives
Yang Wen Long Director

Renhe Pharmacy Co Headlines

No Headlines